Avita Medical, Inc. (NASDAQ:RCEL)

Sunday, May 11, 2025, 4:29 PM
Real Signals, Not Just Hype: A Deep-Dive Open Forum Event [GeoWire Weekly No. 186] | TGEN ACFN PSIX CURI FSI FALC MOJO VMD FTK MUEL BURCA CSBR BLM.V
See All GeoWire Weekly...
Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult patients in the U.S. with paediatric clinical trials and expanded indications in soft-tissue reconstruction and vitiligo underway. It is currently in roll-out across the approximately 136 U.S. burn centres. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the U.S. region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022.

Web site: http://www.avitamedical.com/

Last updated May 22, 2025


Market Data powered by QuoteMedia. Terms of Use